VERTEX PHARMACEUTICALS INC / MA R&D Expense 2008-2022 | VRTX
Beta
What is r&d expense?
Research and development expense represents the costs incurred in discovering and developing new products, processes, or technologies.
What is VERTEX PHARMACEUTICALS INC / MA's current r&d expense?
VERTEX PHARMACEUTICALS INC / MA (VRTX) annual r&d expense for 2021 was $3.05B, a 66.77% increase from 2020. VERTEX PHARMACEUTICALS INC / MA r&d expense for the quarter ending March 31, 2022 was $603.1M.
What was VERTEX PHARMACEUTICALS INC / MA's r&d expense in 2020?
VERTEX PHARMACEUTICALS INC / MA annual r&d expense for 2020 was $1.83B, a 4.27% increase from 2019.
What was VERTEX PHARMACEUTICALS INC / MA's r&d expense in 2019?
VERTEX PHARMACEUTICALS INC / MA annual r&d expense for 2019 was $1.75B, a 23.86% increase from 2018.
What is VERTEX PHARMACEUTICALS INC / MA's 5-year r&d expense CAGR?
VERTEX PHARMACEUTICALS INC / MA r&d expense grew at a compound annual growth rate (CAGR) of 23.84% from FY2016 to FY2021, going from $1.05B to $3.05B over 5 years.
R&D Expense History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Growing
CAGR+23.8%
FY2016
$1.05B
→
FY2021
$3.05B
0809101112131415161718192021
5 years selected
R&D Expense History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2021 | $3.05B | +66.8% | 10-K |
| FY2020 | $1.83B | +4.3% | 10-K |
| FY2019 | $1.75B | +23.9% | 10-K |
| FY2018 | $1.42B | +6.9% | 10-K |
| FY2017 | $1.32B | +26.4% | 10-K |
| FY2016 | $1.05B | +5.2% | 10-K |
| FY2015 | $995.9M | +16.4% | 10-K |
| FY2014 | $855.5M | -3.0% | 10-K |
| FY2013 | $882.1M | +15.2% | 10-K |
| FY2012 | $765.9M | +8.2% | 10-K |
| FY2011 | $707.7M | +11.0% | 10-K |
| FY2010 | $637.4M | +15.8% | 10-K |
| FY2009 | $550.3M | +6.5% | 10-K |
| FY2008 | $516.9M | - | 10-K |
Company: VERTEX PHARMACEUTICALS INC / MATicker: VRTXSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →